Pertussis Infection in Adolescents and Adults With Prolonged Cough
NCT01597687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 337
Last updated 2019-08-09
Summary
This study aims to determine the burden of pertussis infection among adolescents and adults with prolonged cough in four Asian countries, namely Malaysia, Philippines, Taiwan and Thailand. This study also aims to assess the health economic (HE) impact of pertussis.
Conditions
- Pertussis
Interventions
- PROCEDURE
-
Blood collection
1 blood sample will be collected from each subject.
- OTHER
-
Data collection
Quality of Life and HE questionnaires.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-20
- Primary Completion
- 2013-05-02
- Completion
- 2013-05-02
Countries
- Malaysia
- Taiwan
- Thailand
Study Locations
More Related Trials
-
Pertussis (Tdap) Vaccination in Pregnancy
NCT01698346 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
NCT00004422 ·Status: COMPLETED ·Phase: PHASE3
-
First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine
NCT01188512 ·Status: COMPLETED ·Phase: PHASE1
-
Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy
NCT06114160 ·Status: NOT_YET_RECRUITING
-
A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants
NCT02145624 ·Status: COMPLETED ·Phase: PHASE4
-
Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine
NCT02453048 ·Status: COMPLETED ·Phase: PHASE1
-
Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines
NCT01129362 ·Status: COMPLETED
-
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
NCT02569879 ·Status: COMPLETED
-
Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation
NCT01890447 ·Status: COMPLETED
-
Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age
NCT00379977 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths
NCT00158808 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States
NCT03973905 ·Status: COMPLETED
-
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NCT06605755 ·Status: RECRUITING ·Phase: NA
-
Pertussis Vaccination in Pregnant Women
NCT03909126 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccination In Pregnancy Gene Signature: VIP Signature Study
NCT03284515 ·Status: COMPLETED
-
Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines
NCT05193734 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine
NCT01986322 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of Intramuscular TAK-816 in Healthy Infants
NCT02074345 ·Status: COMPLETED ·Phase: PHASE3
-
Gambia Pertussis Study (GaPs)
NCT03606096 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
NCT06817187 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China
NCT01044316 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
NCT02458183 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age
NCT01995175 ·Status: COMPLETED ·Phase: NA
-
Confirmatory Study of BK1310 in Healthy Infants
NCT03891758 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)
NCT00092469 ·Status: COMPLETED ·Phase: PHASE3